Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
BALANCE investigators and collaborators; Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. BALANCE investigators and collaborators, et al. Among authors: geddes jr. Lancet. 2010 Jan 30;375(9712):385-95. doi: 10.1016/S0140-6736(09)61828-6. Epub 2010 Jan 19. Lancet. 2010. PMID: 20092882 Clinical Trial.
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.
Geddes JR, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu LM, Hainsworth J, Attenburrow MJ, Simon J, Goodwin GM, Harrison PJ; CEQUEL Investigators and Collaborators. Geddes JR, et al. Lancet Psychiatry. 2016 Jan;3(1):31-39. doi: 10.1016/S2215-0366(15)00450-2. Epub 2015 Dec 11. Lancet Psychiatry. 2016. PMID: 26687300 Free article. Clinical Trial.
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial.
Saunders KE, Cipriani A, Rendell J, Attenburrow MJ, Nelissen N, Bilderbeck AC, Vasudevan SR, Churchill G, Goodwin GM, Nobre AC, Harmer CJ, Harrison PJ, Geddes JR. Saunders KE, et al. Among authors: geddes jr. Trials. 2016 Mar 2;17(1):116. doi: 10.1186/s13063-016-1230-7. Trials. 2016. PMID: 26936776 Free PMC article. Clinical Trial.
Reprogramming psychiatry: stem cells and bipolar disorder.
Harrison PJ, Cader MZ, Geddes JR. Harrison PJ, et al. Among authors: geddes jr. Lancet. 2016 Feb 27;387(10021):823-5. doi: 10.1016/S0140-6736(16)00235-X. Epub 2016 Feb 26. Lancet. 2016. PMID: 26972063 No abstract available.
Innovative approaches to bipolar disorder and its treatment.
Harrison PJ, Cipriani A, Harmer CJ, Nobre AC, Saunders K, Goodwin GM, Geddes JR. Harrison PJ, et al. Among authors: geddes jr. Ann N Y Acad Sci. 2016 Feb;1366(1):76-89. doi: 10.1111/nyas.13048. Ann N Y Acad Sci. 2016. PMID: 27111134 Free PMC article. Review.
The Emerging Neurobiology of Bipolar Disorder.
Harrison PJ, Geddes JR, Tunbridge EM. Harrison PJ, et al. Among authors: geddes jr. Trends Neurosci. 2018 Jan;41(1):18-30. doi: 10.1016/j.tins.2017.10.006. Epub 2017 Nov 20. Trends Neurosci. 2018. PMID: 29169634 Free PMC article. Review.
The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study.
Atkinson LZ, Colbourne L, Smith A, Harmer CH, Nobre AC, Rendell J, Jones H, Hinds C, Mould A, Tunbridge EM, Cipriani A, Geddes JR, Saunders KEA, Harrison PJ. Atkinson LZ, et al. Among authors: geddes jr. Trials. 2019 Feb 12;20(1):120. doi: 10.1186/s13063-019-3175-0. Trials. 2019. PMID: 30755265 Free PMC article.
254 results